Phase I clinical trials with WAL 2014, a new muscarinic agonist for the treatment of Alzheimer's disease
- 1 February 1995
- journal article
- clinical trial
- Published by Elsevier in Life Sciences
- Vol. 56 (11-12), 883-890
- https://doi.org/10.1016/0024-3205(95)00024-z
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- WAL 2014 - A muscarinic agonist with preferential neuron-stimulating propertiesLife Sciences, 1993
- Discrimination of tetrahydroaminoacridine responders by a single dose pharmaco-EEG in patients with Alzheimer's diseaseNeuroscience Letters, 1991
- Muscarinic Receptor SubtypesNew England Journal of Medicine, 1989
- EEG brain mapping in evaluating the time‐course of the central action of DUP 996‐a new acetylcholine releasing drug.British Journal of Clinical Pharmacology, 1989
- Cholinergic receptors in aging and Alzheimer's diseaseProgress in Neuro-Psychopharmacology and Biological Psychiatry, 1986
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982
- Alzheimer's Disease and Senile Dementia: Loss of Neurons in the Basal ForebrainScience, 1982
- Ein Verfahren zur Bestimmung des relativen Wassergehaltes des Stratum corneum der menschlichen HautArchives of Dermatological Research, 1981
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979
- Human Memory and the Cholinergic SystemArchives of Neurology, 1974